Page last updated: 2024-08-24

plerixafor and Aortic Aneurysm, Abdominal

plerixafor has been researched along with Aortic Aneurysm, Abdominal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allaire, E; Dai, J; Franck, G; Gervais, M; Michineau, S; Wagner-Ballon, O1

Other Studies

1 other study(ies) available for plerixafor and Aortic Aneurysm, Abdominal

ArticleYear
Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.
    Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:8

    Topics: Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Benzylamines; Bone Marrow Transplantation; Calcium Chloride; Chemokine CXCL12; Chemotaxis; Cyclams; Disease Models, Animal; Green Fluorescent Proteins; Guinea Pigs; Heterocyclic Compounds; Heterografts; Humans; Inflammation Mediators; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Smooth Muscle; Rats; Rats, Inbred F344; Receptors, CXCR4; Time Factors; U937 Cells

2014